VSTM
Verastem, Inc.
$5.73
+0.16 (+2.87%)
At close · Jul 15
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“In accordance with the applicable accounting standards, these conditions raise substantial doubt about the Company's ability to continue as a going concern for twelve months after the date the condensed consolidated financial statements are issued.”View the 10-Q filed May 7, 2026
Market Cap
$507.03M
Shares
87,873,639
Press releases and events scraped from the company's investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-06-23 | Verastem Oncology VS-7375 TARGET-D Conference Call | Conference |
| 2026-06-03 | Jefferies Global Healthcare Conference | Conference |
| 2026-05-20 | RBC Global Healthcare Conference | Conference |
| 2026-05-19 | HCW 4th Annual BioConnect Investor Conference | Conference |
| 2026-05-07 | Verastem Oncology 1Q26 Earnings Call | Earnings call |
| 2026-03-04 | Verastem Oncology 4Q/FY25 Earnings Call | Earnings call |
| 2026-02-11 | Guggenheim Emerging Outlook: Biotech Summit 2026 | Event |
| 2025-11-04 | Verastem Oncology 3Q25 Earnings Call | Earnings call |
| 2025-08-07 | Verastem Oncology 2Q25 Earnings Call | Earnings call |
Source: https://investor.verastem.com/